Biotech

All Articles

Pfizer takes $230M hit after axing fell short DMD genetics therapy

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) genetics treatment breakdown has blown a $230 thou...

AC Immune sees 'site' potential in Alzheimer's medication records

.After greater than 20 years of deal with neurodegenerative illness, Swiss biotech hvac Immune syste...

GSK falls ph. 2 HPV vaccination over absence of best-in-class prospective

.GSK has broken up a period 2 human papillomavirus (HPV) vaccine from its own pipe after deciding th...

OS Treatments refiles $6M IPO to cash HER2 medication, preclinical ADCs

.Operating system Therapies are going to specify on the NYSE American inventory swap today through a...

ALX's fizzling CD47 response rate sends out supply spiraling down

.ALX Oncology's phase 2 stomach cancer cells action cost has actually damaged. After finding its CD4...

Ionis axes eye condition from intendeds of Roche-partnered prospect after records let down

.Yet Another of Ionis Pharmaceuticals' essential midphase readouts has actually disappointed require...

Biogen's chief executive officer mentioned no dangerous handle 2023. He prepares to become vibrant

.While Biogen's pharma peers are searching for late-stage properties along with little bit of threat...

Instil refills pipeline in $2B biobucks take care of ImmunOnco

.Instil Bio has been a biotech seeking a pipeline after it junked its own lead assets over the final...

Biogen ignores Denali Alzheimer's collab

.Biogen has actually restored rights to a very early Alzheimer's illness course to Denali Therapeuti...

Takeda touches brand new head of US oncology service-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of substantial leadership hirings, firings an...